Author(s)

Ossama Mansour, Martin Schumacher, Mohammad A. Farrag, Foad Abd-Allah

Freiburg Uniklinik, Neurozentrium, Neuroradiologie Abt., Freiburg, Germany.
Neurology and Interventional Neurology Service Department, Alexandria University Hospital, Alexandria, Egypt.
Neurology Department, Cairo University Hospitals, Cairo, Egypt.

Intracranial atherosclerotic disease (ICAD) represents a major cause of stroke and transient ischemic attacks. The prevalence and natural course of ICAD are closely related to race and ethnicity. The best treatment for ICAD is a crucial issue; data from recent trials indicate that aggressive medical management and life style modifications are better than endovascular treatments for prevention of recurrent stroke in high-risk patients with ICAD. Endovascular treatment is still an option for subgroup of patients who are not responded to optimal medical therapy.

Intracranial Atherosclerosis, Medical Therapy, Endovascular Treatment

Mansour, O. , Schumacher, M. , Farrag, M. and Abd-Allah, F. (2014) Intracranial Atherosclerosis: The Natural History and Management Strategies. World Journal of Cardiovascular Diseases, 4, 350-360. doi: 10.4236/wjcd.2014.47044.